Navigation Links
Raptor Pharmaceutical Corp. Announces Closing of $7.5 Million Registered Direct Offering
Date:12/23/2009

p with the Company's process; that Raptor's patents are not sufficient to protect essential aspects of its technology; that competitors may invent better technology; and that Raptor's products may not work as well as hoped or worse, that the Company's products may harm recipients. As well, Raptor's products may never develop into useful products and even if they do, they may not be approved for sale to the public. Raptor cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors are described in greater detail in the Company's filings from time to time with the Securities and Exchange Commission (the "SEC"), which Raptor strongly urges you to read and consider, including Raptor's current report on Form 8-K as filed with the SEC on November 17, 2009; the joint proxy statement/prospectus on Form S-4 filed with the SEC on August 19, 2009; Raptor's annual report on Form 10-K filed with the SEC on March 27, 2009; and Raptor's quarterly report on Form 10-Q filed with the SEC on August 11, 2009, all of which are available free of charge on the SEC's web site at http://www.sec.gov. Subsequent written and oral forward-looking statements attributable to Raptor or to persons acting on its behalf are expressly qualified in their entirety by the cautionary statements set forth in Raptor's reports filed with the SEC. Raptor expressly disclaims any intent or obligation to update any forward-looking statements.


    For more information, please contact:

    Kim R. Tsuchimoto, CFO
    (415) 382-1390
    ktsuchimoto@raptorpharma.com

    The Ruth Group

    Sara Ephraim Pellegrino (investors)
    (646) 536-7002
    spellegrino@theruthgroup.com

    Janine McCargo (media)
    (646) 536-7033
    '/>"/>
SOURCE Raptor Pharmaceutical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Raptor Pharmaceutical Corp. Announces $7.5 Million Securities Offering
2. Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
3. Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis
4. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
5. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
6. Raptor Pharmaceutical Expands Board of Directors
7. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
8. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
9. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
10. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
11. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Physician E-sampling is becoming well established across ... key marketing sales tactic in recent years. However, some ... a supplement to traditional sampling. According ... E-sampling has been seeded across multiple therapeutic areas- including ... has been in place for five or more years ...
(Date:9/4/2015)...  Janssen Research & Development, LLC (Janssen) announced ... has accepted for Priority Review the Biologics License ... patients with multiple myeloma who are refractory to ... agent (IMiD), or who have received three or ... and an IMiD. This is referred to as ...
(Date:9/4/2015)... -- Fair Rate Funding, a lawsuit funding firm located in ... increase in lawsuit filings in connection with the blood thinning ... Philadelphia Court of Common Pleas has ... Louisiana multi---district litigation (MDL), located in ... Louisiana , the filings are also on the ...
Breaking Medicine Technology:Current and Future Trends in Physician E-Sampling Programs for the Pharmaceutical Industry 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3
(Date:9/5/2015)... ... ... lists continue to increase and budgets continue to be cut, teachers are finding it harder ... has found a way to help with their Pencils 4 Schools Campaign. This year, ... past years. Because of that, the amount of pencils donated has doubled. ...
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article ... American Dental Association presented data showing that it is safe for pregnant women to ... women that had undergone local anesthesia with a group that hadn’t, researchers were able ...
(Date:9/4/2015)... , ... September 04, 2015 , ... The Schmidt National ... Tanya De La Paz. , Schmidt National Law Group, a leading firm in ... of California against Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates for injuries ...
(Date:9/4/2015)... ... 2015 , ... After wearing the same uniforms for six seasons, the Sprayberry ... effort to assist the team, the Jones Agency, a locally owned insurance firm that ... for the new uniforms. , As is so often the case with high school ...
(Date:9/4/2015)... ... September 04, 2015 , ... Keeping mold top of mind is ... is quite common. Mold can grow anywhere - on carpet, clothing, food, paper, and ... excessive moisture and water in the home is key to preventing mold growth, which ...
Breaking Medicine News(10 mins):Health News:‘Pencils 4 Schools’ Campaign 2015 Exceeds Expectations from Previous Year 2Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4
... vessels in the brain , , WEDNESDAY, April 9 (HealthDay ... may be at greater risk of Alzheimer,s disease, a ... public health implications given the increasing numbers of people ... study author Dr. Elina Ronnemaa, of Uppsala University, said ...
... Ritalin, Provigil, beta blockers used to boost focus, ... (HealthDay News) -- One in five respondents to ... drugs" -- such as ADHD and heart medications ... , The most popular drug was Ritalin (methylphenidate), ...
... ALEXANDRIA, Va. and SUNNYVALE, Calif., April 9 ... announced today that it,has received a cash ... benefiting,non-profit organizations in health care, the arts, ... this unrestricted grant to increase online and,web-based ...
... Contrary to the currently accepted model of T-cell development, ... have found that juvenile cells on their way to ... cells or other blood-cell types versus only being committed ... weeks issue of Nature, and have implications for better ...
... ADHD, heart problems becoming popular, survey finds , , WEDNESDAY, ... to a new survey acknowledges using so-called "cognition-enhancing drugs" ... stimulate their focus, concentration or memory. , The most ... treat attention deficit hyperactivity disorder, but has emerged in ...
... Barbara Ann Karmanos,Cancer Institute is accepting nominations for ... The award recognizes an outstanding cancer,survivor who exemplifies ... journey to survive cancer. The award will be ... June 19. Nominations are,open to all cancer survivors., ...
Cached Medicine News:Health News:Diabetes in Middle Age Raises Alzheimer's Risk 2Health News:Diabetes in Middle Age Raises Alzheimer's Risk 3Health News:Professionals Use Drugs to Sharpen Their Minds, Survey Finds 2Health News:Professionals Use Drugs to Sharpen Their Minds, Survey Finds 3Health News:$250,000 Grant Awarded to National Hospice and Palliative Care Organization from Technology Grant Program 2Health News:$250,000 Grant Awarded to National Hospice and Palliative Care Organization from Technology Grant Program 3Health News:$250,000 Grant Awarded to National Hospice and Palliative Care Organization from Technology Grant Program 4Health News:Cells on path to becoming mature T-cells more flexible than commonly thought 2Health News:Cells on path to becoming mature T-cells more flexible than commonly thought 3Health News:Unlikely Drugs Emerge as 'Cognition Enhancers' 2Health News:Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27 2
Shandon Slide Mailers and Envelopes...
Shandon Slide File Storage System...
Modular Specimen Filing System has five cells that can hold either slides or tissue cassettes....
... The Integre Duo is the ... proven,red and green wavelengths. This ... to instantly,select either a red ... which maximizes,treatment options and ensures ...
Medicine Products: